BridgeBio Pharma Basic EPS 2018-2025 | BBIO

BridgeBio Pharma basic eps for the twelve months ending March 31, 2025 was $-3.56, a 10.22% increase year-over-year.

  • BridgeBio Pharma annual basic eps for 2024 was $-0.003B, a 27.09% decline from 2023.
  • BridgeBio Pharma annual basic eps for 2023 was $-0.004B, a 21.17% increase from 2022.
  • BridgeBio Pharma annual basic eps for 2022 was $-0.003B, a 16.41% decline from 2021.

BridgeBio Pharma Basic EPS 2018-2025 | BBIO

  • BridgeBio Pharma annual basic eps for 2024 was $-0.003B, a 27.09% decline from 2023.
  • BridgeBio Pharma annual basic eps for 2023 was $-0.004B, a 21.17% increase from 2022.
  • BridgeBio Pharma annual basic eps for 2022 was $-0.003B, a 16.41% decline from 2021.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$15.5B
Dr Reddy's Laboratories (RDY)$11.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M